Bendamustine and Brentuximab vedotin
About
Membership operator: AND
Therapies: 2
Therapies
Bendamustine (tx:ncit:C73261)
Brentuximab vedotin (tx:ncit:C66944)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| HSE (1) | CD30 + | Hodgkin Lymphoma | Bendamustine, Brentuximab vedotin |